ClinicalTrials.gg
Not yet recruitingNCT07846306GestaversoUpdated Sep 29, 2026

Effectiveness of Gestaverso Virtual Reality Birth Preparation in Women With Previous Negative Birth Experiences

An interventional study of Gestaverso and Control group in Fear of Childbirth and Childbirth-Related Anxiety, sponsored by Fundación de investigación HM. Not yet recruiting. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Fundación de investigación HM · Not applicable, Interventional, and Prevention

How we know

Updated Sep 29, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
124
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

A previous negative childbirth experience can increase fear and anxiety about giving birth again. This study aims to determine whether Gestaverso, a virtual reality-based childbirth preparation program, can help reduce fear of childbirth and improve the birth experience in pregnant women who have previously experienced a negative birth.

The study will include 124 pregnant women who have given birth at least once before and report a previous negative childbirth experience. Participants will be randomly assigned to one of two groups.

One group will receive an individualized childbirth preparation session using Gestaverso, a virtual reality program guided by a trained midwife. During the approximately 60-minute session, participants will experience a simulated childbirth journey, practice breathing and relaxation techniques, learn strategies for managing contractions, and become familiar with the hospital environment and different stages of labor. Their birth partner will also be encouraged to participate.

The other group will receive usual childbirth preparation provided by midwives, without virtual reality.

Participants will complete questionnaires about their fear of childbirth before the intervention and their childbirth experience after giving birth. The researchers will compare the results between the two groups to assess whether virtual reality-based childbirth preparation may help women with previous negative birth experiences feel more prepared for childbirth and have a more positive birth experience.

Read the detailed description

A previous negative childbirth experience may contribute to increased fear and anxiety during subsequent pregnancies. Women who have experienced a distressing or traumatic birth may develop negative expectations about future childbirth, potentially affecting their emotional well-being and confidence in their ability to cope with labor.

Conventional childbirth preparation programs provide information about pregnancy, labor, pain management, and coping strategies. However, women with previous negative birth experiences may benefit from additional approaches that address the emotional aspects of childbirth and help them become familiar with the birth environment in a safe and controlled setting.

Virtual reality (VR) offers an immersive educational experience that allows pregnant women to become familiar with different stages of labor, practice coping strategies, and develop confidence in managing childbirth-related situations. Although VR has been investigated for pain and anxiety management during labor, its potential as a prenatal preparation tool specifically for women with previous negative childbirth experiences remains insufficiently explored.

Gestaverso is an immersive VR-based childbirth preparation program designed to simulate the childbirth journey, from the onset of labor at home to hospital admission, labor progression, and birth. The program combines visual, auditory, tactile, and sensory stimuli with professional guidance from a trained midwife.

This multicenter, randomized controlled trial will compare Gestaverso with usual childbirth preparation provided by midwives. Participants will be randomly allocated to two parallel groups in a 1:1 ratio.

The Gestaverso intervention consists of one individualized 60-minute session, including a 10-minute briefing, approximately 40 minutes of immersive VR simulation, and a 10-minute debriefing. The experience is guided by a midwife certified in Gestaverso training and adapted to the participant's individual needs.

During the simulation, participants will experience different childbirth scenarios, including the onset and progression of contractions at home, the transition to the hospital, admission procedures, and the different stages of labor. They will practice breathing, relaxation, movement, pain management strategies, and communication with healthcare professionals. The birth partner will also be involved in learning supportive techniques.

The control group will receive usual childbirth preparation delivered by midwives through group-based educational sessions, either in person or online. These sessions address third-trimester symptoms, signs of labor, types of birth, contraction management, breathing techniques, and pelvic movement.

The study will be conducted at three hospitals in Spain: HM Puerta del Sur, HM Nuevo Belén, and HM Montepríncipe.

The study aims to determine whether Gestaverso can reduce fear of childbirth and improve the childbirth experience compared with usual childbirth preparation in women with previous negative birth experiences. It will also explore participants' satisfaction with and acceptance of virtual reality as a childbirth preparation tool.

02

Conditions studied

  • Fear of Childbirth
  • Childbirth-Related Anxiety

Keywords

  • Gestaverso
  • Virtual Reality
  • Childbirth Preparation
  • Fear of Childbirth
  • Childbirth-Related Anxiety
  • Negative Birth Experience
  • Traumatic Childbirth
  • Prenatal Education
  • Childbirth Experience
03

In context

Lead sponsor

Fundación de investigación HM is the lead sponsor of 23 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant women aged 18 years or older.
  • Pregnant women at or beyond 32 weeks of gestation.
  • Having experienced at least one previous childbirth.
  • Reporting a previous negative childbirth experience, defined by an affirmative response to the question: "Was there any moment during your previous childbirth that you found distressing or traumatic?"
  • Ability to read and understand the language in which the childbirth preparation program is delivered.
  • Willingness to participate voluntarily and provide written .

Exclusion criteria

Exclusion Criteria:

  • Women who have never given birth before (primiparous women).
  • Previous psychiatric diagnosis or anxiety disorder requiring active treatment.
  • Multiple pregnancies, high-risk pregnancies, or obstetric complications that may limit participation.
  • Cognitive or sensory impairments that prevent the use of virtual reality.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
124 participants (estimated)

Study arms

  • Experimental
    Gestaverso Virtual Reality Childbirth Preparation

    Participants assigned to this arm will receive an individualized 60-minute childbirth preparation session using Gestaverso, an immersive virtual reality program guided by a certified midwife. The session consists of a 10-minute briefing, approximately 40 minutes of immersive simulation, and a 10-minute debriefing. The simulation recreates the childbirth journey, from the onset of labor at home to hospital admission, labor progression, and birth. Participants will practice breathing, relaxation, pelvic movement, non-pharmacological pain management strategies, and communication with healthcare professionals. Their birth partner will also participate in the experience and learn techniques to provide physical and emotional support during labor.

    Behavioral: Gestaverso

  • Active comparator
    Usual Childbirth Preparation

    Participants assigned to this arm will receive usual childbirth preparation provided by midwives through group-based educational sessions, either in person or online, according to their preferences. The program consists of approximately 3 to 4 hours of education covering third-trimester symptoms, signs of labor, types of birth, contraction management, breathing techniques, and pelvic movement. Educational materials, recorded sessions, and support for questions will be available when needed. Participants will not receive virtual reality-based childbirth preparation.

    Behavioral: Control group

Interventions

  • BehavioralGestaverso

    Virtual Reality-Based Childbirth Preparation (Gestaverso)

  • BehavioralControl group

    Control group

06

What researchers measure

Primary outcomes

  1. Fear of Childbirth Assessed Using the Wijma Delivery Expectancy/Experience Questionnaire (W-DEQ)

    The Wijma Delivery Expectancy/Experience Questionnaire (W-DEQ) will be used to assess fear of childbirth. The W-DEQ-A will be administered during pregnancy, before the intervention, to assess anticipatory fear of childbirth, while the W-DEQ-B will be administered after childbirth to assess the emotional experience of giving birth. Each version consists of 33 items scored on a 6-point Likert scale (0-5), with a total score ranging from 0 to 165. Higher scores indicate greater fear of childbirth or a more negative childbirth experience. Positively worded items are reverse-scored before calculating the total score. W-DEQ scores will be compared between the Gestaverso intervention group and the usual childbirth preparation group.

    Time frame: During pregnancy, before the intervention (baseline), and after childbirth (postpartum assessment), approximately 6-8 weeks from baseline.

Secondary outcomes

  1. Childbirth Experience Assessed Using the Childbirth Experience Questionnaire (CEQ-E)

    Childbirth experience will be assessed using the Spanish version of the Childbirth Experience Questionnaire (CEQ-E), a validated patient-reported experience measure consisting of 22 items across four domains: own capacity (8 items), professional support (5 items), perceived safety (6 items), and participation (3 items). Nineteen items are scored using a 4-point Likert scale, while three items use a visual analogue scale subsequently converted into four categories. Higher scores indicate a more positive childbirth experience. Childbirth experience scores will be compared between the Gestaverso intervention group and the usual childbirth preparation group.

    Time frame: After childbirth, during the postpartum assessment (approximately 6-8 weeks from baseline).

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Soriano-Vidal FJ, Oliver-Roig A, Cabrero-Garcia J, Congost-Maestre N, Dencker A, Richart-Martinez M. The Spanish version of the Childbirth Experience Questionnaire (CEQ-E): reliability and validity assessment. BMC Pregnancy Childbirth. 2016 Nov 24;16(1):372. doi: 10.1186/s12884-016-1100-z. PubMed 27884123 ↗
  • Roldan-Merino J, Ortega-Cejas CM, Lluch-Canut T, Farres-Tarafa M, Biurrun-Garrido A, Casas I, Castrillo-Perez MI, Vicente-Hernandez MM, Jimenez-Barragan M, Martinez-Mondejar R, Hurtado-Pardos B, Cabrera-Jaime S. Validity and reliability of the Spanish version of the "Wijma Delivery Expectancy/Experience Questionnaire" (W-DEQ-B). PLoS One. 2021 Apr 26;16(4):e0249942. doi: 10.1371/journal.pone.0249942. eCollection 2021. PubMed 33901208 ↗
  • Storksen HT, Garthus-Niegel S, Vangen S, Eberhard-Gran M. The impact of previous birth experiences on maternal fear of childbirth. Acta Obstet Gynecol Scand. 2013 Mar;92(3):318-24. doi: 10.1111/aogs.12072. PubMed 23278249 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Jun 2027, 7 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2026
First posted
Sep 29, 2026
StartEst.
Nov 1, 2026
Primary completionEst.
Jun 30, 2027
CompletionEst.
Jul 2027
Last update
Sep 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07846306
Lead sponsor
Fundación de investigación HM
Responsible party
Sponsor
First posted
Sep 29, 2026
Start date
Nov 1, 2026 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Sep 29, 2026

Study contacts

Cayetana Ruiz Zaldibar, PhD
Contact
crzaldibar@ucjc.edu
695829472

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion